Business ❯ Corporate Governance ❯ Leadership ❯ CEO Statements

Strategic Decisions

Kimberly-Clark to Acquire Tylenol Owner Kenvue in $48.7 Billion Cash-and-Stock Deal

The merger awaits shareholder and regulatory approval before an expected close in the second half of 2026.

Porsche Ends In‑House Battery Cell Plan, Turns Cellforce Into R&D Unit

Kroger Plans to Close 60 Underperforming U.S. Stores Over 18 Months

Macy's Cuts Profit Forecast, Holds Sales Target Under Tariff Pressures